Viracta Therapeutics Overview

Life ScienceCompany

Where is Viracta Therapeutics headquartered?

Viracta Therapeutics is headquartered in Cardiff, California.

What is Viracta Therapeutics’ revenue?

Viracta Therapeutics disclosed revenue of 51M USD for 2023 and 51M USD for 2022.

How many employees does Viracta Therapeutics have?

Viracta Therapeutics has 40 employees.

What sector is Viracta Therapeutics in?

Viracta Therapeutics is a life science company.

When was Viracta Therapeutics founded?

Viracta Therapeutics was founded in 2007.

Viracta Therapeutics

Viracta Therapeutics, Inc.

2533 South Coast Highway 101 Suite 210,
Cardiff, California 92007
United States,
(858) 400-8470
www.viracta.com

Viracta Therapeutics is a precision oncology company targeting virus-associated malignancies. Viracta’s proprietary investigational drug, nanatinostat, is currently being evaluated in combination with the antiviral agent valganciclovir as an oral combination therapy in Phase 2 clinical trial for EBV-positive lymphomas. Viracta Therapeutics was founded in 2007 and is headquartered in Cardiff, California.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.0/yr) # 1 - - - - - 1
Sell (0.0/yr) # - - - - - - 0
  1

Top M&A Advisors

Financial Deals
Evercore Group
1
Legal Deals
Wilson Sonsini Goodrich & Rosati
1

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.